Cargando…
Cost-effectiveness of integrated collaborative care for comorbid major depression in patients with cancer()
OBJECTIVES: Comorbid major depression is associated with reduced quality of life and greater use of healthcare resources. A recent randomised trial (SMaRT, Symptom Management Research Trials, Oncology-2) found that a collaborative care treatment programme (Depression Care for People with Cancer, DCP...
Autores principales: | Duarte, A., Walker, J., Walker, S., Richardson, G., Holm Hansen, C., Martin, P., Murray, G., Sculpher, M., Sharpe, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pergamon Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678258/ https://www.ncbi.nlm.nih.gov/pubmed/26652589 http://dx.doi.org/10.1016/j.jpsychores.2015.10.012 |
Ejemplares similares
-
Cost-effectiveness of collaborative care for the treatment of major depressive disorder in primary care. A systematic review
por: van Steenbergen-Weijenburg, Kirsten M, et al.
Publicado: (2010) -
The second Symptom Management Research Trial in Oncology (SMaRT Oncology-2): a randomised trial to determine the effectiveness and cost-effectiveness of adding a complex intervention for major depressive disorder to usual care for cancer patients
por: Walker, Jane, et al.
Publicado: (2009) -
Cost-utility of collaborative care for the treatment of comorbid major depressive disorder in outpatients with chronic physical conditions. A randomized controlled trial in the general hospital setting (CC–DIM)
por: Goorden, Maartje, et al.
Publicado: (2017) -
Reflecting the real value of health care resources in modelling and cost-effectiveness studies—The example of viral load informed differentiated care
por: Revill, Paul, et al.
Publicado: (2018) -
An integrative collaborative care model for people with mental illness and physical comorbidities
por: Ee, C., et al.
Publicado: (2020)